378 Development of a clinical candidate TCR for mutant KRAS using a high-precision cell-based platform

• Sara Horta,
• Anette Brass,
• Ryan Hill,
• Luke Pase,
• Hugh Salter,
• Daniela Casarrubea,
• Josefine Dunst,
• Miriam Masia-Balague,
• Tiphane Parrot,
• Athina Totomi,
• Hannes Uchtenhagen,
• Shenqiu Wang,
• Reagan Jarvis

Affiliations

Sara Horta

Anocca AB, Södertälje, Sweden

Anette Brass

Division of Clinical Microbiology F68, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden

Ryan Hill

12 Department of Psychology, Louisiana State University, Baton Rouge, Louisiana, USA

Luke Pase

Anocca AB, Södertälje, Sweden

Hugh Salter

Anocca AB, Södertälje, Sweden

Daniela Casarrubea

Anocca AB, Södertälje, Sweden

Josefine Dunst

Anocca AB, Södertälje, Sweden

Miriam Masia-Balague

Anocca AB, Södertälje, Sweden

Tiphane Parrot

Anocca AB, Södertälje, Sweden

Athina Totomi

Anocca AB, Södertälje, Sweden

Hannes Uchtenhagen

Anocca AB, Södertälje, Sweden

Shenqiu Wang

Anocca AB, Södertälje, Sweden

Reagan Jarvis

Anocca AB, Södertälje, Sweden